Kraglund, Kristian Lundsgaard
Mortensen, Janne Kaergaard
Johnsen, Søren Paaske
Andersen, Grethe
Grove, Erik Lerkevang http://orcid.org/0000-0002-1466-0865
Article History
Received: 25 July 2019
Accepted: 12 December 2019
First Online: 27 December 2019
Competing interests
: The authors report the following conflicts outside the submitted work. K.L.K. and J.K.M. have no conflicts of interest. S.P.J. has received speaker honoraria or consultancy fees from Bayer, Bristol-Myers Squibb and Pfizer, and research grants from Bristol-Myers Squibb, and Pfizer. G.A. has received fees from MSD, AstraZeneca, and Boehringer Ingelheim. E.L.G. has received speaker honoraria or consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, MSD, Portola Pharmaceuticals and Roche. He is an investigator in the THEMIS, SATELLITE and FLAVOUR studies (AstraZeneca) and has received research grants from Boehringer Ingelheim. The study drug was bought from a pharmacy with no association to the manufacturer (Sandoz).